- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07459218
IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania
March 10, 2026 updated by: Duke University
IDEAS for Hope: A Brief Telehealth Intervention to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania
In this project, the investigators will conduct a clinical trial to test the effectiveness and implementation of IDEAS for Hope, a 3-session telehealth counseling intervention delivered by nurses, to reduce suicidality and improve HIV care engagement among PLWH in Tanzania.
The investigators will also examine mechanisms of change and implementation outcomes of the intervention, including cost-effectiveness, to disseminate a feasible, scalable, and sustainable intervention and implementation package to address a critical mental health comorbidity in HIV care.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Detailed Description
Suicide is a leading cause of death among people living with HIV (PLWH) worldwide and PLWH in Tanzania are two to three times as likely to die by suicide compared to people without HIV.
Mental health challenges are also closely linked to poor HIV outcomes, including lapses in clinic attendance, poor medication adherence, risk of HIV transmission, and AIDS-related death.
Yet when PLWH receive mental health treatment that addresses barriers to HIV treatment adherence, both mental health and HIV outcomes improve.
The investigators are developing innovative approaches to bridge the mental health treatment gap in Tanzania, including telehealth and nurse-led counseling interventions.
The investigators previously developed and conducted a pilot feasibility randomized controlled trial of IDEAS for Hope, a 3-session telehealth counseling intervention, led by nurses, to reduce suicide risk and improve HIV care engagement in Tanzania.
The IDEAS for Hope intervention, grounded in Motivational Interviewing, CBT, and Problem-Solving Therapy frameworks, facilitates HIV education, stigma reduction, and social support to address social determinants of suicide risk.
The pilot trial with 60 PLWH who were experiencing suicidal ideation demonstrated clear feasibility and acceptability of IDEAS for Hope, as well as strong trends toward intervention efficacy to reduce suicide risk.
The long-term objective of this research is to develop a scalable implementation package to expand care, reduce suicide risk, and improve HIV care engagement in Tanzania.
In Aim 1, the investigators will determine the effectiveness of IDEAS for Hope to reduce suicide risk and improve HIV care engagement in an individually randomized controlled trial.
Based on the pilot trial, the investigators hypothesize that IDEAS for Hope will reduce suicidal plan and intent to near zero and will improve HIV care engagement by 17% at 6-month follow-up, which will be statistically superior to brief safety planning.
In Aim 2, the investigators will explore mechanisms of change to identify how and for whom IDEAS for Hope is most effective.
The investigators will analyze the effect of hypothesized mediators of suicide risk and HIV care engagement, including self-efficacy, depression, anxiety, and stigma; potential moderators include sex, age, and severity of baseline symptoms.
These data will inform future refinement for at-risk groups and adaptation to other settings.
In Aim 3, the investigators will evaluate implementation outcomes, including cost-effectiveness, guided by the Consolidated Framework for Implementation Research (CFIR).
The investigators hypothesize that IDEAS for Hope will be effectively expanded to 12 clinic sites, with a favorable Incremental Cost-Effectiveness Ratio.
Structured surveys and qualitative interviews with patients and providers will assess fidelity and sustainability outcomes for implementation.
Given the emerging evidence for telehealth and nurse-led approaches, IDEAS for Hope has great potential to reduce the mental health treatment gap in Tanzania.
The research is innovative, yet fundamentally essential, and supports NIH Strategic Objectives to prevent suicide across the lifespan in low- and middle-income countries, address mental health comorbidities of HIV, and strengthen the HIV care continuum.
Study Type
Interventional
Enrollment (Estimated)
600
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Brandon A Knettel, Ph.D.
- Phone Number: (919) 660-1218
- Email: brandon.knettel@duke.edu
Study Locations
-
-
-
Moshi, Tanzania
- Kilimanjaro Clinical Research Institute
-
Contact:
- Blandina Mmbaga, MD, MMED, PhD
- Phone Number: +255 27 275 4201
- Email: b.mmbaga@kcri.ac.tz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adult
- Living with HIV
- Attending HIV care appointments
- Self-report experiencing thoughts of suicide in the last 30 days
Exclusion Criteria:
- Physically or cognitively unable to provide informed consent or complete study procedures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: IDEAS for Hope
3-session, nurse-delivered, telehealth counseling intervention developmed by Knettel and colleagues
|
The IDEAS for Hope framework integrates Joiner's Interpersonal Theory to address stigma, burdensomeness, and other drivers of suicide risk and improve HIV care engagement.
This includes theoretical grounding in Motivational Interviewing-enhanced safety planning (MI-SafeCope), stigma reduction, cognitive-behavioral therapy with adherence counseling (CBT-AD), and problem-solving therapy.
MI-SafeCope improves coping for suicide risk by developing an individualized safety plan and facilitating social support.
The integration of MI into standard safety planning goes beyond identifying coping strategies to facilitate values-driven improvement in health behavior and address the unique drivers of suicide risk among PLWH in Tanzania.
|
|
Active Comparator: Brief Safety Planning
Single session brief safety planning intervention (BSI) developed by Stanely & Brown
|
The single-session safety planning intervention (SPI) will be provided according to protocols developed by Stanley & Brown.
The SPI involves collaboratively creating a personalized, step-by-step plan to help individuals recognize warning signs, use coping strategies, seek support, and reduce access to means during a suicidal crisis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with Suicidal thinking
Time Frame: 6 months
|
Self-report of actual thoughts of suicide in the last 30 days
|
6 months
|
|
Number of participants with a Suicidal plan
Time Frame: 6 months
|
Self-report of plan to attempt suicide
|
6 months
|
|
Number of participants with Suicidal intent
Time Frame: 6 months
|
Self-report of intent to attempt suicide
|
6 months
|
|
Number of participants with Suicide preparatory behavior
Time Frame: 6 months
|
Self-report of preparatory behavior such as writing a suicide note or preparing materials to attempt suicide
|
6 months
|
|
Number of participants with Suicide attempt
Time Frame: 6 months
|
Self-report of harming oneself with the intention of ending one's life
|
6 months
|
|
Number of participants with HIV care engagement
Time Frame: 6 months
|
Single triangulated variable (yes/no) integrating self-reported antiretroviral medication adherence, HIV clinic attendance, and HIV viral load
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Brandon A Knettel, Ph.D., Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
January 31, 2031
Study Completion (Estimated)
June 30, 2031
Study Registration Dates
First Submitted
March 4, 2026
First Submitted That Met QC Criteria
March 4, 2026
First Posted (Actual)
March 9, 2026
Study Record Updates
Last Update Posted (Actual)
March 12, 2026
Last Update Submitted That Met QC Criteria
March 10, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Blood-Borne Infections
- Urogenital Diseases
- Genital Diseases
- Immune System Diseases
- Behavioral Symptoms
- Infections
- RNA Virus Infections
- Virus Diseases
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Self-Injurious Behavior
- Slow Virus Diseases
- Suicide
- HIV Infections
- Behavior
- Suicide Prevention
- Acquired Immunodeficiency Syndrome
- Health Behavior
Other Study ID Numbers
- Pro00119742
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Age, sex, ethnicity, socioeconomic status, depression symptoms, distress, suicide risk, suicide coping self-efficacy, hopelessness, reasons for living, anxiety symptoms, traumatic stress symptoms, impairment, resilience, social support, quality of life, study feedback, method and date of HIV diagnosis, antiretroviral therapy (ART) use and date of initiation, ART adherence, persistence, and retention, beliefs about ART, stigma, HIV knowledge, HIV acceptance.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicide Prevention
-
Mental Health Services in the Capital Region, DenmarkKarolinska InstitutetCompleted
-
University of Sao PauloNot yet recruitingSuicide Ideation | Suicide Attempts
-
University of North Carolina, Chapel HillVillage Heartbeat, Inc.RecruitingSuicide | Suicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
VA Office of Research and DevelopmentNot yet recruiting
-
George Washington UniversityUniversity of Rochester; Mt. Sinai School of Medicine, New York, New York; American...Recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Not yet recruitingSuicide | Suicide Risk | Suicide Attempt | Suicide Ideation | Suicide PreventionSpain
-
VA Office of Research and DevelopmentNot yet recruiting
-
Yale UniversityNational Institute of Mental Health (NIMH); PossibleRecruiting
-
University GhentRecruitingSuicidal Ideation | Suicide | Suicide PreventionBelgium
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Robert Wood Johnson FoundationRecruitingSuicide | Suicide Attempt | Suicide Ideation | Suicide PreventionUnited States
Clinical Trials on IDEAS for Hope
-
Duke UniversityNational Institute of Mental Health (NIMH); Kilimanjaro Christian Medical Centre...CompletedHIV Infections | Quality of Life | Suicidal Ideation | Suicide | Adherence, Medication | Treatment Adherence and Compliance | Stigma, Social | DisclosureTanzania
-
University of MichiganNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingViolence PreventionUnited States
-
Catholic University of the Sacred HeartCompletedHealthy Participants | Young AdultsItaly
-
Duke UniversityKilimanjaro Christian Medical Centre, TanzaniaNot yet recruitingAlcohol Use Disorder | Suicide Prevention
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; University... and other collaboratorsCompletedCancer Patients | Supportive Care | Young AdultUnited States
-
Cynthia GerhardtOhio State UniversityTerminated
-
The Hospital for Sick ChildrenChildren's Hospital Los Angeles; Rutgers Cancer Institute of New Jersey; Inova...Recruiting
-
Children's Hospital Los AngelesActive, not recruitingQuality of Life | Psychological DistressUnited States
-
Children's Hospital Los AngelesCompletedStem Cell TransplantationUnited States
-
Indiana UniversityCompletedStigma, Social | TransgenderismUnited States